Novo Nordisk BV

Novo Nordisk is a global healthcare company with 87 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.

Headquartered in Denmark, Novo Nordisk employs more than 29,300 employees in 76 countries, and markets its products in 179 countries.

Novo Nordisk’s B shares are listed on the NASDAQ OMX Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO).
Type: GOLDEN
Address: Flemingweg 18, 2408 AV Alphen a/d Rijn, P.O. Box 443, The Netherlands
Website: ww.novonordisk.nl
Phone: +31-172 44 94 94
Fax: +31-172 42 47 09
 
This website requires Flash Player 9 or later. If you can not view this site you probably need to update your system with this plug-in for your browser.